资讯库
更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
罗氏制药管线进展与股价飙升17%后,是否该重新评估其投资时机? - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st
先搜索,再按来源或主题继续收窄。
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st